Maybe $1 on MHRA approval for GBM alone? If a partnership with BP is announced in close proximity to MHRA approval, I would think $3-4 is possible. If they submit with the FDA then this might get us a a bit higher as well. There has been talk about tissue agonist designation but after talking with the Company, I personally dont think so. But then again I dont think they would disclose this to anyone, even if they know the TA designation is a possibility. Most of this is all speculation, so I just concentrate on GBM alone, because we know for a FACT that is what they applied for....nothing more, nothing less.
Market Data 
Markets 
AI
